These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19249693)

  • 1. Using cardiac resynchronization therapy diagnostics for monitoring heart failure patients.
    Adamson PB
    Heart Fail Clin; 2009 Apr; 5(2):249-60. PubMed ID: 19249693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices.
    Braunschweig F; Mortensen PT; Gras D; Reiser W; Lawo T; Mansour H; Sogaard P; Stegemann B; Bruns HJ; Linde C;
    Am J Cardiol; 2005 May; 95(9):1104-7. PubMed ID: 15842984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic capabilities of devices for cardiac resynchronization therapy.
    Gardini A; Lupo P; Zanelli E; Bisetti S; Cappato R
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):186-9. PubMed ID: 19829134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
    Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
    Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure.
    Koneru JN; Steinberg JS
    Curr Opin Cardiol; 2008 Jan; 23(1):9-15. PubMed ID: 18281821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of implantable sensors for management of heart failure.
    Kadhiresan K; Carlson G
    Stud Health Technol Inform; 2004; 108():219-27. PubMed ID: 15718650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM; Haas GJ; Gans B; Abraham WT
    Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of device diagnostics in the outpatient management of heart failure.
    Germany R; Murray C
    Am J Cardiol; 2007 May; 99(10A):11G-6G. PubMed ID: 17512417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using devices for physiologic monitoring in heart failure.
    Rathman L; Repoley J; Delgado S; Trupp R
    J Cardiovasc Nurs; 2008; 23(2):159-68. PubMed ID: 18382259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy and atrial fibrillation.
    Kamath GS; Steinberg JS
    Cardiol J; 2009; 16(1):4-10. PubMed ID: 19130410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of device diagnostics as an educational tool to improve patient adherence.
    Rathman L
    Am J Cardiol; 2007 May; 99(10A):29G-33G. PubMed ID: 17512420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of Holter monitoring in congestive heart failure.
    Cygankiewicz I; Zareba W; de Luna AB
    Cardiol J; 2008; 15(4):313-23. PubMed ID: 18698539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating device monitoring into the infrastructure and workflow of routine practice.
    Adamson PB
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S42-6. PubMed ID: 16955059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the pathophysiological basics of cardiac resynchronization therapy.
    Auricchio A; Prinzen FW
    Europace; 2008 Jul; 10(7):797-800. PubMed ID: 18482999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study.
    Arya A; Block M; Kautzner J; Lewalter T; Mörtel H; Sack S; Schumacher B; Søgaard P; Taborsky M; Husser D; Hindricks G;
    Eur J Heart Fail; 2008 Nov; 10(11):1143-8. PubMed ID: 18805053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the cardiac rhythm management device population: the RATE Registry design.
    ;
    Am Heart J; 2009 Jun; 157(6):983-7.e1. PubMed ID: 19464407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating monitoring into the infrastructure and workflow of routine practice: OptiVol.
    Small R
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S47-55. PubMed ID: 16955060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.